News for 'National Institute for Medical Research'

Covid: Parl panel stresses swift strategy evolution for next-gen vaccines

Covid: Parl panel stresses swift strategy evolution for next-gen vaccines

Rediff.com20 Dec 2023

The ICMR-National Institute of Virology has been regularly undertaking studies to understand the protective efficacy of COVID-19 vaccines against emerging variants.

Does Your Heel Hurt While Walking?

Does Your Heel Hurt While Walking?

Rediff.com19 Aug 2024

Heel pain can be due to plantar fasciitis, Achilles tendonitis or heel pad syndrome, says rediffGURU Dr Shakeeb Ahmed Khan.

Bharat Biotech's Covaxin shipped to 11 cities in India

Bharat Biotech's Covaxin shipped to 11 cities in India

Rediff.com13 Jan 2021

After having received the government purchase order for 55 lakh doses, Bharat Biotech shipped the first batch of vaccines (each vial containing 20 doses) to Gannavaram (Vijayawada), Guwahati, Patna, Delhi, Kurukshetra, Bangalore, Pune, Bhubaneswar, Jaipur, Chennai and Lucknow.

Nipah mortality rate much higher than Covid, says ICMR

Nipah mortality rate much higher than Covid, says ICMR

Rediff.com16 Sep 2023

He asserted that all efforts are on to contain the spread of the virus in Kerala.

Homeopathic cure for cancer catches US fancy

Homeopathic cure for cancer catches US fancy

Rediff.com23 Jan 2004

American's National Institute of Health will study a cancer care protocol developed by a Kolkata-based father-son homeopath duo.

India registered 9.3 lakh cancer deaths, 2nd highest in Asia

India registered 9.3 lakh cancer deaths, 2nd highest in Asia

Rediff.com3 Jan 2024

Researchers found that India, along with China and Japan, were the three leading countries in Asia in terms of number of new cases and deaths, where they say cancer has become a more significant public health threat with 94 lakh new cases and 56 lakh deaths in 2019.

Kerala govt trying to find source of Nipah outbreak

Kerala govt trying to find source of Nipah outbreak

Rediff.com16 Sep 2023

After identifying the man who was the patient zero or index case of the Nipah virus outbreak in Kerala, the state government on Saturday began looking for the source and place from where he got infected by seeking details of his mobile tower locations.

Farmers tear-gassed after offering tea, flower shower; several hurt

Farmers tear-gassed after offering tea, flower shower; several hurt

Rediff.com8 Dec 2024

A group of 101 farmers resumed their foot march to Delhi on Sunday to press the Centre for various demands, including a legal guarantee for Minimum Support Price (MSP). However, they were stopped at the barricading by Haryana Police who cited a prohibitory order clamped by the Ambala administration. The farmers have been pressing for various demands, including a legal guarantee for MSP, a farm debt waiver, pension for farmers and farm labourers, no hike in electricity tariff, withdrawal of police cases (against farmers), and "justice" for the victims of the 2021 Lakhimpur Kheri violence. Reinstatement of the Land Acquisition Act, 2013 and compensation to the families of farmers who died during the previous agitation in 2020-21 are also part of their demands.

New Covid strain: Total 29 people in India test positive

New Covid strain: Total 29 people in India test positive

Rediff.com1 Jan 2021

These include the 25 cases which were announced till Thursday. "All the 29 persons are in physical isolation in health facilities," an official said.

NIV isolates monkeypox virus, paves way for vaccine, diagnostic kit

NIV isolates monkeypox virus, paves way for vaccine, diagnostic kit

Rediff.com27 Jul 2022

The National Institute of Virology (NIV) in Pune under the ICMR has isolated the monkeypox virus from the clinical specimen of a patient, which can pave the way for development of diagnostic kits and vaccines against the disease, officials said on Wednesday.

'My son wants to study hotel management. Pls help'

'My son wants to study hotel management. Pls help'

Rediff.com10 Apr 2024

rediffGURU Maxim Emmanuel offers expert advice on how to make an informed career choice.

Health secy reviews status of passengers from UK

Health secy reviews status of passengers from UK

Rediff.com23 Dec 2020

Union Health Secretary Rajesh Bhushan reviewed the status of passengers coming from the UK to India and found positive in Maharashtra, Karnataka, Telangana, Tamil Nadu, West Bengal, Goa, Punjab, Gujarat and Kerala and their response measures in a meeting held through video conferencing.

'ICMR fast tracking Covid vaccine for PM announcement on I-Day'

'ICMR fast tracking Covid vaccine for PM announcement on I-Day'

Rediff.com4 Jul 2020

'Forcing the development of an indigenous vaccine as a cure for COVID-19, bypassing all health & safety norms, to be announced by PM Modi on Independence Day is fraught with horrendous human costs'

Covaxin's 50 pc efficacy adequate for Covid, say experts

Covaxin's 50 pc efficacy adequate for Covid, say experts

Rediff.com26 Nov 2021

The decline in the effectiveness of Covaxin, India's indigenous COVID-19 vaccine, from 77.8 per cent to 50 per cent during a Delta-driven case surge in April and May this year is neither bad nor surprising, say scientists.

US says Covaxin successfully neutralises Delta variant

US says Covaxin successfully neutralises Delta variant

Rediff.com30 Jun 2021

The NIH said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2, first identified in the United Kingdom and India, respectively.

'I've Not Backstabbed Anybody'

'I've Not Backstabbed Anybody'

Rediff.com18 Nov 2024

'They are attacking my wife; they are attacking our 13-month-old daughter. They are saying that I do drugs.' 'I'm giving an open challenge to Mr Nawab Malik and Ms Sana Malik let's go to the labs and let's do the medical test of our family and your family.'

J&J in talks with India for study of single-dose vaccine

J&J in talks with India for study of single-dose vaccine

Rediff.com9 Apr 2021

India is currently using two vaccines for COVID-19 -- one developed by Oxford University and AstraZeneca and the other developed by Bharat Biotech in collaboration with the Indian Council of Medical Research-National Institute of Virology. Both the vaccines are being manufactured within the country by domestic firms.

The Vaccine War Review: Absorbing Drama

The Vaccine War Review: Absorbing Drama

Rediff.com28 Sep 2023

The Vaccine War leans towards stoking nationalistic fervour, but that shouldn't stop you from watching a film that is solemn about the Indian scientific community's achievement, notes Mayur Sanap.

'This Isn't About Rejecting Our Heritage'

'This Isn't About Rejecting Our Heritage'

Rediff.com27 Aug 2024

'...but subjecting our heritage to rigorous evidence-based understanding.'

Modi, FLOTUS to talk science with desi students

Modi, FLOTUS to talk science with desi students

Rediff.com21 Jun 2023

A visit to the National Science Foundation in Alexandria, Virginia is likely to be the first public engagement of the prime minister, which would be hosted by the First Lady, the White House said on Tuesday.

Special group to tackle SARS

Special group to tackle SARS

Rediff.com24 Apr 2003

The doctors treating SARS suspects or patients will use the Defence Research Development Organisation made Nuclear-Biological-Chemical weapon masks.

Giving NEET-UG Exam? Get Expert Advice Here

Giving NEET-UG Exam? Get Expert Advice Here

Rediff.com6 Mar 2024

rediffGURU Mayank Chandel offers advice to students preparing for IIT-JEE and NEET-UG after class 12.

Over 90 lakh samples have been tested for COVID-19 so far

Over 90 lakh samples have been tested for COVID-19 so far

Rediff.com2 Jul 2020

The officials of Indian Council of Medical Research (ICMR) also said there are now 1,065 testing labs in the country -- 768 in the public sector and 297 in private.

These Scientists Shaped India

These Scientists Shaped India

Rediff.com15 Aug 2023

I suggest we build a Vigyan Mandir (Temple of Science) with the ambience of a place of worship, so that it becomes a destination for pilgrims. We should embed on its walls bronze plaques describing each scientist mentioned here along with about a dozen of our ancient mathematicians, recommends Professor Kalyan Singhal, historian of science and technology.

PM reviews preparations for vaccination against COVID-19

PM reviews preparations for vaccination against COVID-19

Rediff.com30 Jun 2020

The PM directed officials to evaluate various technology tools to ensure efficient and timely vaccination in due course of time. He also emphasised that detailed planning for such large scale vaccination should be undertaken immediately.

Covaxin maker to pay compensation in case of side effects

Covaxin maker to pay compensation in case of side effects

Rediff.com16 Jan 2021

"The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vaccine," the consent form said.

COVID-19 tests in India cross 2-crore mark

COVID-19 tests in India cross 2-crore mark

Rediff.com3 Aug 2020

There are now 1,348 testing labs in the country comprising 914 in the public sector and 434 private labs.

Want To Live Longer? Read This!

Want To Live Longer? Read This!

Rediff.com4 Jan 2023

Adults who stay well-hydrated appear to be healthier, develop fewer chronic conditions, such as heart and lung disease, and live longer than those who may not get sufficient fluids.

PIO woman cancer-free after experimental drug trial in UK

PIO woman cancer-free after experimental drug trial in UK

Rediff.com4 Jul 2022

An Indian-origin woman who was given just months to live a few years ago is celebrating on Monday after doctors say she is showing no evidence of breast cancer following a clinical trial at a UK hospital.

India The Diplomatic Ambassador In Global Crises

India The Diplomatic Ambassador In Global Crises

Rediff.com16 Sep 2024

Times have changed, situations have changed, but the basic nature of superpower geo-politics remains the same and so also India's diplomacy -- call it non-alignment, strategic autonomy or neutrality; it all depends on the time scale, notes Rup Narayan Das.

Common cold T cells may offer Covid protection: Study

Common cold T cells may offer Covid protection: Study

Rediff.com10 Jan 2022

The researchers believe their findings provide a blueprint for a second-generation, universal vaccine that could prevent infection from current and future SARS-CoV-2 variants, including Omicron.

Revealed: How India launched its war against COVID-19

Revealed: How India launched its war against COVID-19

Rediff.com30 Jul 2020

'The lockdown was for both: To flatten the curve or more correctly, delay the rapid spread of COVID outbreak, and to create healthcare infrastructure.'

Centre asks states to keep suspected monkeypox cases in isolation

Centre asks states to keep suspected monkeypox cases in isolation

Rediff.com26 May 2022

According to sources, so far only one traveller from Canada having symptoms of monkeypox infection had been isolated.

World University Rankings: Non-IITs in Top 100

World University Rankings: Non-IITs in Top 100

Rediff.com11 Apr 2022

The Saveetha Institute of Medical and Technical Sciences. The Indian School of Mines, Dhanbad. Vinay Umarji explains why these two universities have made India proud.

NEET row: NTA DG shunted out; Centre orders CBI probe

NEET row: NTA DG shunted out; Centre orders CBI probe

Rediff.com23 Jun 2024

The Centre on Saturday night announced that the probe into alleged irregularities in the medical entrance exam NEET will be handed over to the CBI for a comprehensive investigation.

Covaxin 50% effective against symptomatic Covid: Lancet

Covaxin 50% effective against symptomatic Covid: Lancet

Rediff.com24 Nov 2021

Results of an interim study recently published in The Lancet showed that two doses of Covaxin, also known as BBV152, had 77.8 per cent efficacy against symptomatic disease and present no serious safety concerns.

'Unprecedented vaccine trial in India'

'Unprecedented vaccine trial in India'

Rediff.com23 Dec 2020

Bharat Biotech recruited 13,000 participants for the Phase-3 clinical trial of Covaxin. This is one of the largest efficacy trials held in the country.

India's first COVID-19 vaccine gets nod for human trials

India's first COVID-19 vaccine gets nod for human trials

Rediff.com30 Jun 2020

COVAXIN, developed by Hyderabad-based Bharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virology, has got the nod for human clinical trials from the Drug Controller General of India

Covaxin safe, shows 77.8% efficacy against symptomatic Covid: Lancet

Covaxin safe, shows 77.8% efficacy against symptomatic Covid: Lancet

Rediff.com12 Nov 2021

The phase 3 trial findings indicate that Covaxin induces a robust antibody response with no severe vaccine-related adverse events or deaths reported among the trial participants, the authors of the study said.